The GEMiniTM family of image detector panels is primarily designed for use in radiation therapy but the panels can also be used in industrial radiography systems. The market potential for C-RAD Imaging's GEM technology is at least 150 MUSD per year. GEMiniTM products represent world class performance and comprise state of the art technology including new unique patented inventions. These new inventions enable superior image quality and real time detection combined with lower cost of ownership. The evaluation of the GEMini detector will be managed by Dr. Piotr Zygmanski, Staff Physicist at Brigham and Women's Hospital (BWH) and Instructor in Radiation Oncology at Harvard Medical School. The detector will initially be evaluated as a so called EPID in radiation therapy followed by a proposal to develop new functionalities to the system. The evaluation process is planned to start at the beginning of the second quarter of 2009. Erik Hedlund, CEO, C-RAD AB: "The C-RAD Imaging group is encouraged by the great interest for the GEMini technology and its potential for use in radiation therapy expressed by Dr. Zygmanski at the Department of Radiation Oncology, Brigham and Women´s Hospital at Harvard. We are looking forward to a close cooperation with the Department and are excited about the possibilities to add new functionalities to the system." Piotr Zygmanski, PhD, Staff Physicist at BWH and Instructor in Radiation Oncology, Harvard Medical School confirmed that he is planning to evaluate GEMini for imaging of patient anatomy and verification of deposited dose. For further information: Erik Hedlund, CEO C-RAD AB, Telephone 018- 666931, E-mail: erik.hedlund@c-rad.se